Light-to-moderate alcohol consumption is linked to a reduced risk of heart attack, stroke and death among those with heart disease, according to a study published in the journal BMC Medicine on July 26.

Avenue Therapeutics Inc. said on June 14 the U.S. Food and Drug Administration had once again declined to approve the company’s non-opioid painkiller tramadol, sending the drugmaker’s shares lower in trading.

Several biopharmaceutical companies submitted New Drug Applications (NDAs) to the U.S. Food and Drug Administration in recent weeks, covering treatment indications ranging from an opioid overdose to bipolar disorder and rare disease.

Purdue Pharma LP pleaded guilty to criminal charges over the handling of the company’s addictive prescription painkiller OxyContin, capping a deal with federal prosecutors to resolve an investigation into the drugmaker’s role in the U.S. opioid crisis.

Walmart Inc. filed a lawsuit against the federal government, seeking clarity on the roles and legal responsibilities of pharmacists and pharmacies in filling opioid prescriptions.

O.C Suboxone understands the severity of opioid use disorder and is working to raise awareness on healthier alternatives to treat chronic pain.

Addressing Spikes in Substance Use Disorder Following COVID-19 Date: Wednesday, September 23, 2020 Time: 01:00 – 02:00 PM EDT Duration: 1 Hour   Register Here   As communities worry about a second spike in COVID-19, many are overlooking the current spike in substance use disorder (SUD). Prolonged social isolation, heightened anxiety and depression, and a […]

Much more often than not, attempting to talk to friends or family members about their potential drug or alcohol abuse is a sensitive, challenging, and sometimes painful undertaking. It is natural for an individual who is addicted to drugs or alcohol, not to recognize the long-term consequences that cause pain and suffering to more people than just themselves. When seeking to help others overcome their addiction and the constant struggle with substance abuse, sometimes it is through those caring friends or family members that the user can finally find some relief2 by setting boundaries.

Med Ad News spoke with Christian Heidbreder, Ph.D., Chief Scientific Officer of Indivior Inc., about some of the barriers to patients seeking treatment for opioid use disorder, how to integrate treatment for opioid use disorder and infectious disease services, and the company’s efforts to provide treatments for those struggling with the disorder.

The first of the Insys Therapeutics executives found guilty of violating the Racketeer Influenced and Corrupt Organizations (RICO) Act in May 2019 was sentenced to 33 months in federal prison.